Laurus Family of Funds

Laurus Labs is a leading research-driven pharmaceutical and biotechnology company headquartered in India, specializing in the manufacture of Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations (FDF), and Synthesis services. The company is a global leader in the production of generic anti-retroviral (ARV) APIs and intermediates, supporting large-scale HIV treatment programs worldwide. Beyond its core small molecule business, Laurus Labs has expanded into high-growth biologics and cell therapy sectors through its subsidiary Laurus Bio and strategic investments in CAR-T cell therapy developers like ImmunoACT. The company operates state-of-the-art R&D and manufacturing facilities that cater to major pharmaceutical markets in the US, Europe, and emerging economies.